ELDN Earnings Date: Nov 13, 2026 (Estimated) — Eledon Pharmaceuticals, Inc.
NASDAQ
Updated
When is ELDN's next earnings date?
Eledon Pharmaceuticals, Inc. (ELDN) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20.
How did ELDN do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Eledon Pharmaceuticals, Inc. posted EPS of -$0.27 versus the -$0.16 estimate, a miss of 68.8%. Revenue was $0. The stock's 1-day post-earnings move was -4.3%.
How much does ELDN stock move after earnings?
ELDN beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.9% (up or down) in the day after earnings.
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.16 | -0.27 | -68.75% | $0 | ❌ Miss | -4.32% | -4.86% | -25.14% |
| 2026-05-13 | Q1 2026 | -0.23 | -0.33 | -43.48% | $0 | ❌ Miss | +1.80% | -1.03% | -7.99% |
| 2026-03-19 | Q4 2025 | -0.20 | -0.10 | +50.00% | $0 | ✅ Beat | +1.05% | +3.86% | +45.26% |
| 2025-11-14 | Q3 2025 | -0.24 | -0.21 | +12.50% | $0 | ✅ Beat | -7.95% | -18.18% | -7.39% |
| 2025-03-20 | Q4 2024 | -0.34 | -0.64 | -88.24% | $0 | ❌ Miss | +2.03% | -0.87% | -13.37% |
| 2024-08-18 | Q2 2024 | -0.30 | -1.06 | -253.33% | $0 | ❌ Miss | +0.92% | +6.23% | -7.69% |
| 2024-03-28 | Q4 2023 | -0.39 | -0.32 | +17.95% | $0 | ✅ Beat | -3.40% | -16.50% | +15.05% |
| 2023-08-10 | Q2 2023 | -0.46 | -0.40 | +13.04% | $0 | ✅ Beat | +1.65% | -2.48% | +10.74% |
Showing last 8 quarters.